Statistics for Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Total visits
| views | |
|---|---|
| Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer | 127 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
File Visits
| views | |
|---|---|
| 13058_2010_Article_2652.pdf | 18 |
Top country views
| views | |
|---|---|
| United States | 46 |
| Chile | 32 |
| Germany | 8 |
| France | 4 |
| Mexico | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 27 |
| Alameda | 6 |
| Concepcion | 5 |
| Kempen | 2 |
| Balingen | 1 |
| Campbell | 1 |
| Hanoi | 1 |
| Jacksonville | 1 |
| Sacramento | 1 |
| Zapopan | 1 |